China Meheco Group Co Ltd
SSE:600056
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
9.58
12.05
|
| Price Target |
|
We'll email you a reminder when the closing price reaches CNY.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Operating Margin
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
Peer Comparison
| Country | Company | Market Cap |
Operating Margin |
||
|---|---|---|---|---|---|
| CN |
C
|
China Meheco Group Co Ltd
SSE:600056
|
16.4B CNY |
Loading...
|
|
| JP |
|
Mitsubishi Corp
TSE:8058
|
15.4T JPY |
Loading...
|
|
| JP |
|
Itochu Corp
TSE:8001
|
15.3T JPY |
Loading...
|
|
| JP |
|
Mitsui & Co Ltd
TSE:8031
|
14.3T JPY |
Loading...
|
|
| US |
|
United Rentals Inc
NYSE:URI
|
57.9B USD |
Loading...
|
|
| JP |
|
Marubeni Corp
TSE:8002
|
8.3T JPY |
Loading...
|
|
| US |
W
|
WW Grainger Inc
XMUN:GWW
|
42.4B EUR |
Loading...
|
|
| US |
|
Fastenal Co
NASDAQ:FAST
|
50.1B USD |
Loading...
|
|
| US |
|
W W Grainger Inc
NYSE:GWW
|
50.7B USD |
Loading...
|
|
| US |
|
Ferguson Enterprises Inc
NYSE:FERG
|
49.3B USD |
Loading...
|
|
| JP |
|
Sumitomo Corp
TSE:8053
|
7.5T JPY |
Loading...
|
Market Distribution
| Min | -409 046.1% |
| 30th Percentile | -1.4% |
| Median | 4.2% |
| 70th Percentile | 10.3% |
| Max | 876.4% |
Other Profitability Ratios
China Meheco Group Co Ltd
Glance View
China Meheco Group Co., Ltd., established in 1984, stands as a prominent player in the Chinese pharmaceutical and healthcare sector. As the company evolved over the decades, it navigated the complex Chinese market by strategically positioning itself across the entire pharmaceutical value chain. This involved investing heavily in research and development, securing partnerships with both domestic and international pharmaceutical companies, and streamlining its distribution network to enhance efficiency. Such endeavors have enabled China Meheco to develop and distribute a wide range of medical products, including active pharmaceutical ingredients, finished drugs, medical devices, and traditional Chinese medicines. The company leverages its robust R&D capabilities to continually bring innovative products to market, which has been a significant source of its revenue. China Meheco's business model thrives on its expansive distribution network and strategic collaborations. By aligning with global pharmaceutical giants, the company not only gains access to cutting-edge technologies and advanced formulations but also expands its market reach beyond China. This dual strategy of innovation and partnership ensures a steady flow of products that cater to diverse healthcare needs. Furthermore, China Meheco capitalizes on its local expertise and deep understanding of regulatory frameworks, allowing it to maneuver efficiently within China's complex healthcare landscape. This approach underpins its ability to capture substantial market share in a competitive industry, driving profitability and positioning the company as a key player in the global pharmaceutical arena.
See Also
Operating Margin is calculated by dividing the Operating Income by the Revenue.
The current Operating Margin for China Meheco Group Co Ltd is 2.7%, which is below its 3-year median of 3.2%.
Over the last 3 years, China Meheco Group Co Ltd’s Operating Margin has decreased from 2.9% to 2.7%. During this period, it reached a low of 2.6% on Jun 30, 2025 and a high of 3.7% on Dec 31, 2022.